In January 2022 Stanford University and Deerfield Management, a healthcare investment firm, collaborated to create Porter Alliance for Innovative Medicines to accelerate translational research into clinical therapeutics. Deerfield has committed up to $130 million and additional scientific and operational support to the collaboration to advance research coming out of Stanford faculty laboratories with a focus on drug prototypes emerging from Stanford’s Innovative Medicines Accelerator (IMA). The IMA is a key partner in the collaboration as it seeks to accelerate the translation of Stanford research discoveries into new medicines while learning more about human biology.
Deerfield Logo
Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. The Firm works across the healthcare ecosystem to connect people, capital, ideas and technology in bold, collaborative and inclusive ways. For more information, please visit www.deerfield.com.
Stanford Logo
Stanford University is dedicated to its founding mission of benefitting society through research and education. Stanford strives to create a sustainable future for all, catalyze discoveries about itself and the world, accelerate the societal impact of its research, and educate students as global citizens. Learn more at Stanford.edu.